---All---
  • ---All---
  • Accession
  • Catalog #

AP2 gamma AntibodyRabbit Monoclonal Antibody

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AJ1045b 100ul 400 ul 2-3 days $ 315.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

AP2 gamma Antibody - Product info

ApplicationWB, IHC
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ92754
ReactivityHuman
Clone NamesEP2692Y
Calculated MW49177 Da
Gene ID 7022
Other Names
TFAP2C, Transcription factor AP-2 gamma, Activating enhancer-binding protein 2 gamma;Transcription factor ERF-1
Target/Specificity
A synthetic peptide corresponding to residues in human AP2 gamma was used as an immunogen.
Dilution
WB~~1:500~1000
IHC~~1:250~500
Format
50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
AP2 gamma Antibody is for research use only and not for use in diagnostic or therapeutic procedures.

AP2 gamma Antibody - Protein Information

Name TFAP2C
Function
Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC
Cellular Location
Nucleus (Probable).

AP2 gamma Antibody - Application data

  • A. Western blot analysis on (A) MCF-7 and (B) SKBR3 cell lysate using anti-AP2-C RabMAb (Cat. #AJ1045b), dilution 1:50,000.

  • B. Immunohistochemical analysis of paraffin-embedded human breast carcinoma using anti-AP2C RabMAb. (Cat. #AJ1045b).

AP2 gamma Antibody - Related products

AJ1045a: AP2 gamma Antibody

AJ1045b: AP2 gamma Antibody

AF1068a: AP-2 gamma Antibody

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Transcription factor gene AP2-C (AP-2 gamma) belongs to a family of four closely related genes. The AP-2 transcription factor has been shown to play an important role in the development of tissues of ectodermal origin and has also been implicated in mammary oncogenesis (2). A physical and functional association between AP-2gamma transcription factor and the Wwox protein has been demonstrated. results suggest that Wwox tumor suppressor protein inhibits AP-2gamma oncogenic activity by sequestering it in the cytoplasm (2). P-2 gamma had been implicated in multiple functions during proliferation and differentiation based on its expression pattern in trophoblast, neural crest, and ectoderm cells in murine embryos. AP-2 gamma seems to be required in early embryonic development because it regulates the genetic programs controlling proliferation and differentiation of extraembryonic trophectodermal cells (3).

REFERENCES

1. Williamson JA, et al. Genomics 35(1):262-4, 1996
2. Ageilan RI, et al. Cancer Res 64(22): 8256-61, 2004
3. Werling U et al. Mol Cell Biol 22(9):3149-56, 2002